Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
A TB-500 variant hub focused on fragment nomenclature clarification, 2mg and 5mg vial fill specifications, identity verification, and B2B documentation review.
Key Review Snapshot
Why buyers trust WUMO
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so TB-500 Vial Supply — 2mg and 5mg Fill Specifications is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
Request scope and availability through the B2B inquiry path.
Request this file through the inquiry path below.
SDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Overview
B2B Review Guide
Before sourcing TB-500, procurement and documentation review teams should confirm whether the inquiry refers to TB-500 as a fragment or to a TB-4 specification. WUMO supplies TB-500 as a fragment under this hub. The TB-4 component in WUMO's Glow Blend is separately specified and subject to project confirmation.
The two fill specifications differ in vial fill quantity, not fragment identity. Fill choice is driven by downstream packaging plan, quotation unit comparability, and MOQ/lead time planning.
This page is for qualified B2B technical evaluation and business-side documentation review only. This page is not intended for individual purchase, consumer use, or product-use guidance.
No. The two names refer to different specifications. WUMO supplies TB-500 as a fragment under this hub. Treating the names as interchangeable at inquiry stage can create documentation review issues.
The TB-4 component in WUMO's Glow Blend is a separately specified component; full-length vs fragment scope is subject to project confirmation.
The two fill specifications differ in vial fill quantity, not in fragment identity. A single hub page lets teams compare fill specifications without duplicate documentation review.
USD per gram or USD per fully built-out packaging configuration produces the most directly comparable view. Per-vial comparison alone can be misleading.
publish_candidate=false; For Daisy review before publishing. product_interest=tb-500-vial-supply
OEM / Private Label
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.